Lupin Reports Impressive Profit Surge Driven by Strong Demand for Respiratory Drugs
Lupin records a major leap in quarterly profits, powered by strong global demand for its respiratory medicines and continued expansion
Read More
Factual Version of a Story
Lupin stock performance